AIM IMMUNOTECH INC. (AIM) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 3.62M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | 9.96M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 12.73M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $3.62M | (m) | (m) | $9.96M | $12.73M | (m) |
| 2026-03-31 | (m) | (m) | $4.00M | $210.00K | (m) | $5.88M | $8.59M | (m) |
| 2025-12-31 | (m) | (m) | $3.55M | $927.00K | (m) | $3.05M | $5.78M | (m) |
| 2025-09-30 | (m) | (m) | $1.88M | (m) | (m) | $2.41M | $5.49M | (m) |
| 2025-06-30 | (m) | (m) | $2.29M | (m) | (m) | $835.00K | $4.13M | (m) |
| 2025-03-31 | (m) | (m) | $1.95M | (m) | (m) | $2.25M | $6.25M | (m) |
| 2024-12-31 | (m) | (m) | $2.31M | (m) | (m) | $3.98M | $8.61M | (m) |
| 2024-09-30 | (m) | (m) | $2.59M | $139.00K | (m) | $7.20M | $13.59M | (m) |
| 2024-06-30 | (m) | (m) | $2.35M | $283.00K | (m) | $10.06M | $15.71M | (m) |
| 2024-03-31 | (m) | (m) | $1.62M | $950.00K | (m) | $10.94M | $16.19M | (m) |
| 2021-03-31 | (m) | (m) | $234.00K | $1.82M | (m) | $63.60M | $74.09M | (m) |
| 2020-12-31 | (m) | (m) | $230.00K | $1.88M | (m) | $54.38M | $64.58M | (m) |
| 2020-09-30 | (m) | (m) | $226.00K | $1.93M | (m) | $54.48M | $64.16M | (m) |
| 2020-06-30 | (m) | (m) | $221.00K | $1.99M | (m) | $40.31M | $50.12M | (m) |
| 2020-03-31 | (m) | (m) | $217.00K | $2.05M | (m) | $31.08M | $42.41M | (m) |
| 2019-12-31 | (m) | (m) | $214.00K | $2.10M | (m) | $8.78M | $20.22M | (m) |
| 2019-09-30 | (m) | (m) | $210.00K | $2.16M | (m) | $11.73M | $22.49M | (m) |
| 2019-06-30 | (m) | (m) | $205.00K | $2.21M | (m) | $2.86M | $13.81M | (m) |
| 2019-03-31 | (m) | (m) | $201.00K | $2.27M | (m) | $4.88M | $15.96M | (m) |
| 2018-12-31 | (m) | (m) | $199.00K | $2.32M | (m) | $1.82M | $13.85M | (m) |
| 2018-09-30 | (m) | (m) | $197.00K | $2.37M | (m) | $4.08M | $15.17M | (m) |
| 2018-06-30 | (m) | (m) | $195.00K | $2.42M | (m) | $4.24M | $15.69M | (m) |
| 2018-03-31 | (m) | (m) | $222.00K | $2.44M | (m) | $4.64M | $16.26M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |